Development of ACE2 loaded decoy liposomes and their effect on SARS-CoV-2 for Covid-19 treatment
- 25 February 2022
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 27 (3) , 290-300
Abstract
SARS-CoV-2 is a novel coronavirus with a positively oriented single-stranded RNA that first appeared in December 2019. In this study, Angiotensin Converting Enzyme 2 (ACE2) loaded decoy liposomes were developed and characterized. ACE2 protein was loaded onto a liposomal carrier system and its toxicity and effectiveness were evaluated in cell culture and in vitro virus neutralization studies. Liposomes were prepared with the film hydration method and adjusted for size with the dialysis membrane method or the ultrasonic homogenization method. All formulations showed high entrapment efficiency between 99.98–79.6%. Liposomes with two different particle sizes above 2 µm and below 500 nm were obtained with the dialysis membrane method and homogenization method. Two optimum formulations, M6-S90 with a PDI value of 0.383 ± 0.053 and particle size of 397.7 ± 28.25 nm which was produced by ultrasonic homogenization and M6-4 with a PDI 0.769 ± 0.205 and particle size of 2606 ± 1396.00 were chosen as optimum formulations for further studies. M6-S90 was stable and showed low toxicity on Calu3 lung epithelial cells. Pre-incubation of M6-S90 with with 3.1 × 105 PFU/mL of SARS-CoV-2 followed by incubation with Vero E6 cells resulted in a 4 log fold change reduction in cell death compared to virus alone. This suggests that MS6-S90 had good neutralization activity on SARS-CoV-2 whilst maintaining viability of the host cell. The novel ACE-2 loaded decoy liposomes described in this study can be further evaluated for the treatment of COVID-19.Keywords
Funding Information
- Turkish Institutes of Health Presidency (8783/8974)
This publication has 33 references indexed in Scilit:
- Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike ProteinViruses, 2012
- Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structureEuropean Journal of Pharmaceutical Sciences, 2010
- Cultured Human Airway Epithelial Cells (Calu-3): A Model of Human Respiratory Function, Structure, and Inflammatory ResponsesCritical Care Research and Practice, 2010
- The synergy between structural stability and DNA-binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexesColloids and Surfaces B: Biointerfaces, 2009
- Effects of frequency and power of ultrasound on the size reduction of liposomeChemistry and Physics of Lipids, 2009
- Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin deliveryJournal of Controlled Release, 2009
- Evaluation of nanoparticle immunotoxicityNature Nanotechnology, 2009
- Preparation of Large Monodisperse VesiclesPLOS ONE, 2009
- Physicochemical Characterization and Stability of Rifampicin Liposome Dry Powder Formulations for InhalationJournal of Pharmaceutical Sciences, 2009
- Phosphatidylcholine vesicles. Formation and physical characteristicsBiochemistry, 1969